Novavax, Inc.: shareholders and insiders

NVAXNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$7.72

November 19, 2026Market cap $1.3B

What Ploutos Investor adds for Novavax

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from 2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 21% since Nov 5, 2026, when the 10-Q these figures come from was filed ($9.78 then, $7.72 on Nov 19, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Jun 23, 2026, from their own Form 4 filings.

8 Form 4s

Bought on the market

–

nobody

Sold on the market

–

nobody

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

  • Jun 20, 2026Richard J RodgersDirector
    Kind
  • Jun 20, 2026Rachel K. KingDirector
    Kind
  • Jun 20, 2026Richard DouglasDirector
    Kind
  • Jun 20, 2026Margaret G McglynnDirector
    Kind
  • Jun 20, 2026David M MottDirector
    Kind
  • Jun 20, 2026Gregg H AltonDirector
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by NVAX's officers and directors from 2005 up to November 18, 2025, 21 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

4 Holders over 5%Nov 10, 2026 Latest filing
  • BlackRock, Inc.
    Share of class8.40%
  • Shah Capital Managementwith 2 more persons
    Share of class6.46%
  • State Street
    Share of class5.40%
  • Vanguard Capital Management
    Share of class5.09%
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Bank of America4.10%Apr 27, 202613G/A
  • The Vanguard Group0.00%Mar 27, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Coatue Management
    In the quarter
  • D.E. Shaw
    In the quarter+1.4%
  • Citadel Advisors (Griffin)
    In the quarter+64%
  • Point72 (Cohen)
    In the quarter
  • Millennium Mgmt (Englander)
    In the quarter-40%
  • Renaissance Technologies
    In the quarter-91%
  • AQR Capital
    In the quarter-83%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 29.1% of its shares outstanding were held short, +2.8% since the report before.

Shares held short
47.35M
29.1%
Since the report before46.05M on Sep 30, 2026
+2.8%
4.3
10.92M
More days to cover thanof 4,578 US-listed companies with enough volume
52%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 44.91M
  • Nov 15, 2023: Shares held short 41.15M
  • Nov 30, 2023: Shares held short 43.11M
  • Dec 15, 2023: Shares held short 45.54M
  • Dec 29, 2023: Shares held short 49.20M
  • Jan 12, 2024: Shares held short 50.91M
  • Jan 31, 2024: Shares held short 52.09M
  • Feb 15, 2024: Shares held short 54.83M
  • Feb 29, 2024: Shares held short 52.74M
  • Mar 15, 2024: Shares held short 48.13M
  • Mar 28, 2024: Shares held short 43.91M
  • Apr 15, 2024: Shares held short 43.77M
  • Apr 30, 2024: Shares held short 44.93M
  • May 15, 2024: Shares held short 45.29M
  • May 31, 2024: Shares held short 38.21M
  • Jun 14, 2024: Shares held short 39.71M
  • Jun 28, 2024: Shares held short 29.53M
  • Jul 15, 2024: Shares held short 31.40M
  • Jul 31, 2024: Shares held short 28.76M
  • Aug 15, 2024: Shares held short 30.50M
  • Aug 30, 2024: Shares held short 31.61M
  • Sep 13, 2024: Shares held short 33.53M
  • Sep 30, 2024: Shares held short 33.88M
  • Oct 15, 2024: Shares held short 35.72M
  • Oct 31, 2024: Shares held short 39.98M
  • Nov 15, 2024: Shares held short 41.51M
  • Nov 29, 2024: Shares held short 39.78M
  • Dec 13, 2024: Shares held short 39.16M
  • Dec 31, 2024: Shares held short 36.92M
  • Jan 15, 2025: Shares held short 38.07M
  • Jan 31, 2025: Shares held short 34.94M
  • Feb 14, 2025: Shares held short 35.45M
  • Feb 28, 2025: Shares held short 39.23M
  • Mar 14, 2025: Shares held short 37.55M
  • Mar 31, 2025: Shares held short 36.88M
  • Apr 15, 2025: Shares held short 41.03M
  • Apr 30, 2025: Shares held short 42.33M
  • May 15, 2025: Shares held short 46.47M
  • May 30, 2025: Shares held short 44.70M
  • Jun 13, 2025: Shares held short 44.48M
  • Jun 30, 2025: Shares held short 46.56M
  • Jul 15, 2025: Shares held short 43.08M
  • Jul 31, 2025: Shares held short 42.31M
  • Aug 15, 2025: Shares held short 38.10M
  • Aug 29, 2025: Shares held short 43.87M
  • Sep 15, 2025: Shares held short 44.72M
  • Sep 30, 2025: Shares held short 43.45M
  • Oct 15, 2025: Shares held short 45.83M
  • Oct 31, 2025: Shares held short 48.32M
  • Nov 14, 2025: Shares held short 50.68M
  • Nov 28, 2025: Shares held short 51.86M
  • Dec 15, 2025: Shares held short 52.59M
  • Dec 31, 2025: Shares held short 54.72M
  • Jan 15, 2026: Shares held short 53.28M
  • Jan 30, 2026: Shares held short 51.18M
  • Feb 13, 2026: Shares held short 50.85M
  • Feb 27, 2026: Shares held short 50.92M
  • Mar 13, 2026: Shares held short 48.63M
  • Mar 31, 2026: Shares held short 44.99M
  • Apr 15, 2026: Shares held short 46.34M
  • Apr 30, 2026: Shares held short 49.48M
  • May 15, 2026: Shares held short 45.28M
  • May 29, 2026: Shares held short 45.97M
  • Jun 15, 2026: Shares held short 45.11M
  • Jun 30, 2026: Shares held short 45.81M
  • Jul 15, 2026: Shares held short 43.82M
  • Jul 31, 2026: Shares held short 45.66M
  • Aug 14, 2026: Shares held short 47.49M
  • Aug 31, 2026: Shares held short 48.78M
  • Sep 15, 2026: Shares held short 49.88M
  • Sep 30, 2026: Shares held short 46.05M
  • Oct 15, 2026: Shares held short 47.35M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading53.4% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 53.4% of the shares in the reported trades were short sales, against 49.8% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
53.4%
The 14 beforeOct 12, 2026 – Oct 29, 2026
49.8%
Change
+3.6 pts
Short sales a dayon average, of 2.19M shares
1.17M
More than atof 3,656 US-listed companies, same days
61%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 46.1%
  • Oct 13, 2026: Short sales 53.4%
  • Oct 14, 2026: Short sales 46.2%
  • Oct 15, 2026: Short sales 47.8%
  • Oct 16, 2026: Short sales 46.8%
  • Oct 19, 2026: Short sales 47%
  • Oct 20, 2026: Short sales 51.7%
  • Oct 21, 2026: Short sales 49.6%
  • Oct 22, 2026: Short sales 55.4%
  • Oct 23, 2026: Short sales 42.6%
  • Oct 26, 2026: Short sales 55%
  • Oct 27, 2026: Short sales 51.9%
  • Oct 28, 2026: Short sales 52.8%
  • Oct 29, 2026: Short sales 52.1%
  • Oct 30, 2026: Short sales 46.7%
  • Nov 2, 2026: Short sales 49.7%
  • Nov 3, 2026: Short sales 50.4%
  • Nov 4, 2026: Short sales 52.5%
  • Nov 5, 2026: Short sales 52.8%
  • Nov 6, 2026: Short sales 40.2%
  • Nov 9, 2026: Short sales 64.2%
  • Nov 10, 2026: Short sales 59.2%
  • Nov 11, 2026: Short sales 63.3%
  • Nov 12, 2026: Short sales 51.4%
  • Nov 13, 2026: Short sales 41.7%
  • Nov 16, 2026: Short sales 51%
  • Nov 17, 2026: Short sales 68%
  • Nov 18, 2026: Short sales 53.2%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

455.0K Insiders' shares0.28% Of the company
  • David M MottDirector
    Directly79.8K
  • Richard DouglasDirector
    Directly73.2K
  • Filip DubovskyPresident, R&D
    Directly66.6K
  • James F YoungDirector
    Directly51.8K
  • Gregg H AltonDirector
    Directly47.7K
  • Richard J RodgersDirector
    Directly47.4K
  • Margaret G McglynnDirector
    Directly44.5K
  • Rachel K. KingDirector
    Directly44.1K

A lower bound: it counts only the 8 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

17 ETFs holding it0.66% The largest weight (XBI)
  • XBIState Street(R) SPDR(R) S&P(R) Biotech ETF
    Weight in the fund0.66%
  • LABUDirexion Daily S&P Biotech Bull 3X Shares
    Weight in the fund0.38%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.12%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.09%
  • FESMFidelity Enhanced Small Cap Core ETF
    Weight in the fund0.09%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.05%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.04%
  • VBKVanguard Small-Cap Growth Index Fund
    Weight in the fund0.04%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.03%
  • VBVanguard Small-Cap Index Fund
    Weight in the fund0.02%

17 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

268 Managers, Q2 2026$1.1B Value of their positions
  • Q3 2025: Managers 251
  • Q4 2025: Managers 237
  • Q1 2026: Managers 260
  • Q2 2026: Managers 268

Institutional investors by quarter

The fund managers holding NVAX, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 268 managers held 117M shares, worth $1.1B. During the quarter 44 opened a position, 36 closed one, 75 added and 86 trimmed.

The largest holders, Q2 2026

  • Shah Capital Management
    In the quarter-4.6%
  • BlackRock
    In the quarter+8.6%
  • State Street
    In the quarter+31%
  • Vanguard Portfolio Management
    In the quarter+6.4%
  • Vanguard Capital Management
    In the quarter+1.8%
  • Sanofi
    In the quarter
  • D.E. Shaw
    In the quarter-27%
  • Geode Capital Management
    In the quarter+7.9%
  • Two Sigma Investments
    In the quarter+565%
  • Coatue Management
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Novavax's filings show?

Who buys and sells is one part of Novavax's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NVAX's shareholders

Didn't find what you were looking for?

Ask us
Have NVAX's insiders bought or sold?

From Jun 23, 2026 to Jun 23, 2026 Novavax's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold NVAX?

7 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $62M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.